Specific serotonin receptor antagonist reduces murine calcific atherosclerosis

Key Points

• Calcific atherosclerosis was significantly reduced with the serotonin receptor antagonist.
• The treatment led to decreased lipid accumulation and inflammation in the vascular system.
• Observational analysis using murine models revealed clear benefits of the antagonist approach.
• These findings support further investigation into serotonin receptor targeting for atherosclerosis treatment.